These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 5722169)

  • 21. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-25.
    Knoll J; Vizi ES
    Pharmacology; 1970; 4(5):278-86. PubMed ID: 5490475
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 24. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 25. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD; Jenden DJ; Mickey MR; Yale C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of (-) 9 -trans-tetrahydrocannabinol and mescaline on the behavior of rats submitted to food competition situations.
    Masur J; Martz RM; Bieniek D; Korte F
    Psychopharmacologia; 1971; 22(2):187-94. PubMed ID: 5124191
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of delta 9-tetrahydrocannabinol and LSD on the acquisition of an active avoidance response in the rat.
    Waser PG; Martin A; Heer-Carcano L
    Psychopharmacologia; 1976 Apr; 46(3):249-54. PubMed ID: 951460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative action of mescaline, LSD 25 and yageine on the central temperature of the rat].
    DELPHAUT J; LANZA M
    J Physiol (Paris); 1960; 52():70-1. PubMed ID: 13815749
    [No Abstract]   [Full Text] [Related]  

  • 30. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969; 19(2):279-85. PubMed ID: 5404353
    [No Abstract]   [Full Text] [Related]  

  • 32. Delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol: behavioral effects and tolerance development.
    Kosersky DS; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1974 Apr; 189(1):61-5. PubMed ID: 4823300
    [No Abstract]   [Full Text] [Related]  

  • 33. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 34. Steroids and moods: correlations in schizophrenics and subjects treated with lysergic acid diethylamide (LSD), mescaline, tetrahydrocannabinol, and synhexyl.
    Hollister LE
    J Clin Pharmacol J New Drugs; 1969; 9(1):24-9. PubMed ID: 5250309
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo effect of LSD, morphine, ethanol and delta9-tetrahydrocannabinol on mouse brain adenosine triphosphatase activity.
    Jain ML; Curtis BM; Bakutis EV
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):229-32. PubMed ID: 4272745
    [No Abstract]   [Full Text] [Related]  

  • 36. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
    VOJTECHOVSKY M; GROF S
    Cesk Psychiatr; 1960 Aug; 56():221-33. PubMed ID: 13781932
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LSD and 5-HTP: tolerance and cross-tolerance relationships.
    Carter RB; Appel JB
    Eur J Pharmacol; 1978 Jul; 50(2):145-8. PubMed ID: 308008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.
    WOLBACH AB; ISBELL H; MINER EJ
    Psychopharmacologia; 1962 Mar; 3():1-14. PubMed ID: 14007904
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.